Reviews
Part of Healthcare Marketing Compliance Guide for Clinics
The Healthcare Marketing Compliance Questions That Keep Coming Back
common healthcare marketing compliance questions cover scope, authority, privacy, claims, vendors, platforms, documentation, enforcement, approval, and correction.
What to take away
- Six questions recurwhich law applies, who signs off, whether the claim holds, whether the vendor is usable, what happens when facts change, and how the answer is recorded.
- HHS and its Office for Civil Rights do not certify people or products as HIPAA compliant, so a vendor badge settles nothing.
- The FTC covers deceptive health claims, the FDA covers drug and device promotion, and state privacy and telehealth rules cover the gaps.
- A compliance officer, legal counsel and a medical reviewer each own a defined judgment, written down and dated.
- Every answer needs an owner, an evidence period, a review date and a stop rule.
The recurring questions, one line each
The recurring questions
- Which law applies. Decide by entity, conduct, jurisdiction, data type, audience and medium. The FTC, FDA, HHS/OCR and state regulators split the work.
- Who approves. The compliance officer or legal counsel signs the copy. A clinician signs clinical accuracy.
- Is the claim supported. Match the net impression of the whole ad to evidence that existed before publication.
- Can the vendor be used. Read the configured data flow and the written contract, not the badge.
- What if facts change. Apply a written stop rule, inventory live copy, then correct and verify.
- How the answer is recorded. One decision record per question, with owner, source, date and next review.
The discipline is to answer them in order and write the answer down. Teams that skip the first one argue about the wrong regulator for weeks. The healthcare marketing compliance guide walks through that classification step before anyone drafts copy.
Which rules and regulators apply
Start with the Federal Trade Commission. Section 5 of the FTC Act bars deceptive advertising, and the agency's health privacy guidance covers digital health communications outside HIPAA.
The Food and Drug Administration regulates promotion of prescription drugs, biologics and medical devices. Its rules require fair balance and adequate risk information.
HHS and its Office for Civil Rights enforce the HIPAA Privacy and Security Rules and the breach notification rule. The HIPAA Privacy Rule overview permits uses for treatment, payment and health care operations. Neither HHS nor OCR certifies vendors or people as compliant.
State law adds privacy statutes, professional advertising rules and telehealth licensure. Washington's My Health My Data Act reaches health data outside HIPAA. Ask counsel which states apply to a campaign.
Canada runs on different rules. The PIPEDA framework governs private-sector health information under ten fair information principles. CASL requires consent for commercial electronic messages, and Ontario's PHIPA adds provincial duties.
Who owns the final decision
The compliance officer owns rule interpretation and the stop rule. Legal counsel owns jurisdiction, contracts and consent language. A medical reviewer signs anything that makes a clinical claim.
Titles vary with size. A solo practice may keep counsel outside. A hospital system may run a weekly review committee. What matters is that a name appears on the record.
The business owner confirms the service is real, current, available and delivered as promised. Reviewers should not approve work beyond the evidence they received. The routine for compliance teams shows how those sign-offs fit a weekly cycle.
Example: a testimonial that becomes a regulated claim
A clinic posts a patient video saying a supplement reversed a diagnosis. The FTC treats that net impression as a health claim needing competent and reliable scientific evidence. If the product is a device or a drug, FDA promotion rules apply as well.
A disclosure cannot create evidence that does not exist. It can only clarify a claim the evidence already supports.
The medical reviewer checks the clinical claim. Counsel checks the testimonial consent and state rules on patient videos. Marketing keeps the approved file next to the copy.
Recording the decision and the evidence
Recording the decision
| Recurring question | Document to keep |
|---|---|
| Which law applies | Written interpretation from counsel, with jurisdiction and date |
| Who approves | Signed approval naming the reviewer role and copy version |
| Is the claim supported | Evidence file with source, publication date and stated limits |
| Can the vendor be used | Business associate agreement, data-flow diagram, monitoring plan |
| What if facts change | Stop rule, copy inventory, correction log, verification note |
The healthcare marketing strategy questions settle what a team is promising before it writes copy. Store the record beside the copy it approved. A reviewer should rebuild the reasoning without asking who remembers. One set of definitions should run through the interface, the export, the meeting note and the correction log.
When facts change or an issue is found
A stop rule should name the trigger, the person who can pull a campaign, and a backup who can act when that person is unreachable. When a claim breaks, inventory every live version: website, ads, email, landing pages, print and scripts.
HIPAA breach notification requires notice to affected individuals without unreasonable delay and no later than 60 days after discovery. Larger breaches also reach HHS. Document the analysis even when no notice is required, and note who reviewed it and when.
Keep rejected options beside the chosen one. The constraint that ruled an option out may change. The healthcare advertising practices that survive review share one habit: the evidence file travels with the copy.
Common questions
Can a disclaimer make an unsupported claim acceptable?
No. A disclosure cannot create missing evidence, and it cannot contradict the main impression. The FTC and FDA read the whole message.
Is an old approval reusable?
Only after checking what changed: the claim, evidence, offer, audience, rules, format, destination, vendor and the service itself.
Should every issue stop every campaign?
No. Written, risk-based stop rules contain the affected activity while owners assess it. Other campaigns continue unless they share the same claim or vendor.
Who decides whether a claim is supported?
The medical reviewer rules on clinical accuracy and the compliance officer rules on substantiation. Counsel decides when the evidence is thin enough to change the wording.
